NOT-EB-24-017: Notice of NIBIB Participation in RFA-NS-25-018: "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"

Notice of NIBIB Participation in RFA-NS-25-018: "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"

Notice Number:

NOT-EB-24-017

Key Dates

Release Date:

October 21, 2024

Related Announcements

September 24, 2024 - BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed). See NOFO RFA-NS-25-018.

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants that effective October 18, 2024, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate in RFA-NS-25-018, "BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)", issued by the National Institutes of Health.

The following text has been added to reflect NIBIB’s participation in the NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.286

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Michael Wolfson
NIBIB/OPESP
Telephone: 301-451-4778
Email: [email protected]